Quantcast

Latest Chronic myelogenous leukemia Stories

Leukemia Drug Prices Too Costly
2013-04-27 06:38:21

redOrbit Staff & Wire Reports - Your Universe Online More than 100 influential oncologists from over 15 different countries have joined forces to demand pharmaceutical companies reduce the prices of potentially life-saving cancer medication, some of which can cost patients in excess of $100,000 per year. In a commentary published Thursday by Blood, the journal of the American Society of Hematology, 120 doctors and researchers specializing in the treatment of chronic myeloid leukemia...

2013-04-25 20:14:26

Increasing, unsustainable prices for leukemia drugs represent larger issue across all cancers The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American...

2013-03-21 14:58:25

Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides. The therapy may not be effective for all patients, but those with trisomy 8 chromosomal disorder have higher rates of stable disease and respond better to treatment with dasatinib,...

2012-12-26 12:47:29

An international team, headed by researchers at the University of California, San Diego School of Medicine, has identified a key enzyme in the reprogramming process that promotes malignant stem cell cloning and the growth of chronic myeloid leukemia (CML), a cancer of the blood and marrow that experts say is increasing in prevalence. The findings are published in the Dec. 24 online early edition of the Proceedings of the National Academy of Sciences (PNAS). Despite the emergence of new...

Rare Leukemia Drug Receives FDA Approval
2012-12-16 06:40:58

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) has approved a new drug for the treatment of two rare forms of leukemia, including chronic myeloid leukemia (CML), various media outlets have reported. Ponatinib, a third-generation, multi-targeted tyrosine kinase inhibitor that will be marketed by Ariad Pharmaceuticals under the brand-name Iclusig, received the go-ahead on Friday, some three months before the agency was required to act on...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related